Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 9,073-9,084 of 23,847
Behavioral study icon
TerminatedNCT03620344

ADHD/Me Bibliotherapy Study

This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In Cincinnati
ADHDOtherFrom 7 Years to 10 Years
Countries
United States
Sponsor
Children's Hospital Medical Center, Cincinnati
Condition
ADHD
Drug study icon
CompletedNCT01786369

Adherence in Patients Admitted to a Psychiatric Unit for Acute Psychosis: an Analysis of Serum Levels of Antipsychotics.

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

In Glen Oaks
Schizophrenia, BipolarityOtherOver 18 Years
Countries
United States
Sponsor
Northwell Health
Condition
Schizophrenia, Bipolarity
Drug study icon
TerminatedNCT00852059

Adherence to Stimulant Treatment in Attention-Deficit Hyperactivity Disorder (ADHD) Patients (ASTA)

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

In Mainz
ADHDDrugA study involving a medication or substance.From 6 Years to 17 Years
Countries
Germany
Sponsor
Prof. Huss
Condition
ADHD
Drug study icon
WithdrawnNCT01981811

Medical Information Device #1 for schizophrenia

This study was withdrawn in the United States. It is testing Medical Information Device #1 for schizophrenia.

Multiple locations, including Cerritos
Bipolarity, SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Bipolarity, Schizophrenia
Drug study icon
OngoingEUCTR 2014-003803-31

Adjunct pioglitazone IN THE TREATMENT OF Bipolarity.

This study is comparing PIOGLITAZONE with placebo for people with bipolarity. Participants receive PIOGLITAZONE or placebo and complete study visits and assessments.

In Spain
BipolarityOther
Countries
Spain
Sponsor
Hospital Universitario Araba (Sede Santiago)
Condition
Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.